United States Biotechnology & Medical Research

Rapport Therapeutics, Inc. (RAPP)

Track

Track

Rapport Therapeutics Inc. experienced significant insider trading activity recently, with executives offloading approximately 14 million USD in shares. These planned sales occurred following a negative earnings report. Despite this selling pressure, the stock price remains elevated, reflecting a 30.9% gain over the past ninety days as it trades near its yearly peak.
Ticker: RAPP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rapport Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
304.97
Quantity 49,859 +37.7%
Value US$750,394
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
123.15
Quantity 76,958 -21.1%
Value US$2,974,856
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
455.03
Quantity 25,887 -45.5%
Value US$3,114,219
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
50.31
Quantity 20,799 -8.9%
Value US$1,046,421
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
49.57
Quantity 18,921 -3.9%
Value US$937,957
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
49.33
Quantity 37,000
Value US$1,825,210
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
50.00
Quantity 13,160 -5.3%
Value US$657,978
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
48.24
Quantity 11,472
Value US$553,409
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
49.90
Quantity 404 -0.2%
Value US$20,160
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
49.01
Quantity 2,092
Value US$102,529
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
48.62
Quantity 5,794 -1.2%
Value US$281,721
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
48.04
Quantity 19,500 -3.8%
Value US$936,846
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
46.90
Quantity 3,664 -0.7%
Value US$171,837
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
46.75
Quantity 8,370 -1.6%
Value US$391,280
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
45.97
Quantity 14,171 -2.6%
Value US$651,492
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
42.74
Quantity 7 -0.0%
Value US$299
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
42.11
Quantity 2,203 -0.4%
Value US$92,762
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
40.57
Quantity 2,729 -0.5%
Value US$110,722
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.72
Quantity 5,481 -1.0%
Value US$217,715
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
43.15
Quantity 1,000 -0.7%
Value US$43,155
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
42.17
Quantity 3,308 -2.1%
Value US$139,506
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
41.39
Quantity 3,792 -2.4%
Value US$156,964
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.09
Quantity 1,900 -1.2%
Value US$76,174
0.6
CHERYL GAULT Officer Officer
Transaction date
Proposed sale
Price
40.39
Quantity 10,000
Value US$403,900
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
40.34
Quantity 876 -0.2%
Value US$35,336
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.77
Quantity 7,344 -1.3%
Value US$292,062
Abraham N. Ceesay Officer Officer
Transaction date
Proposed sale
Price
40.39
Quantity 99,480
Value US$4,017,997
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.00
Quantity 18,572
Value US$742,880
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.25
Quantity 133,618
Value US$5,378,124
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.31
Quantity 5,018
Value US$202,254
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.31
Quantity 5,018
Value US$202,254
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.12
Quantity 271,495
Value US$10,892,705
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
39.99
Quantity 20,225 -7.6%
Value US$808,844
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
39.54
Quantity 20,225
Value US$799,696
3.2
Third Rock Ventures V, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
40.32
Quantity 426,005
Value US$17,175,116
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
35.08
Quantity 10,200 -3.7%
Value US$357,797
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
34.97
Quantity 9,165 -3.2%
Value US$320,537
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
34.17
Quantity 19,365
Value US$661,702
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
34.98
Quantity 500 -0.2%
Value US$17,490
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
34.90
Quantity 360 -0.1%
Value US$12,564
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
33.49
Quantity 360
Value US$12,056
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
28.55
Quantity 2,839 -1.7%
Value US$81,062
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Planned sale
Price
28.04
Quantity 7,161 -4.2%
Value US$200,795
0.6
CHERYL GAULT Officer Officer
Transaction date
Proposed sale
Price
27.84
Quantity 10,000
Value US$278,400
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Planned sale
Price
29.99
Quantity 10,115 -3.4%
Value US$303,355
1.7
KRISHNASWAMY YELESWARAM Officer Officer
Transaction date
Proposed sale
Price
28.25
Quantity 10,115
Value US$285,749
0.6
Gault Cheryl Chief Operating Officer Officer
Transaction date
Sale
Price
28.93
Quantity 2,014 -1.2%
Value US$58,265
0.6
Gault Cheryl Officer Officer
Transaction date
Proposed sale
Price
28.92
Quantity 2,014
Value US$58,236
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.80
Quantity 2,100 -9.2%
Value US$62,573
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.04
Quantity 2,983 -11.6%
Value US$86,639
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.80
Quantity 2,281 -0.4%
Value US$67,970
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.05
Quantity 3,552 -0.6%
Value US$103,191
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Planned sale
Price
29.59
Quantity 2,200 -0.6%
Value US$65,108
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Planned sale
Price
28.95
Quantity 5,400 -1.4%
Value US$156,328
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Planned sale
Price
28.02
Quantity 900 -0.2%
Value US$25,219
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.11
Quantity 5,083 -16.5%
Value US$132,737
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.12
Quantity 5,833 -1.0%
Value US$152,333
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Planned sale
Price
27.40
Quantity 200 -0.1%
Value US$5,480
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Planned sale
Price
26.83
Quantity 8,300 -2.1%
Value US$222,652
1.7
DAVID BREDT Officer Officer
Transaction date
Proposed sale
Price
27.42
Quantity 17,000
Value US$466,140
1.7
DAVID BREDT Officer Officer
Transaction date
Proposed sale
Price
30.05
Quantity 6,567
Value US$197,338
1.7
Bredt David Chief Scientific Officer Officer
Transaction date
Sale
Price
30.05
Quantity 6,567 -1.6%
Value US$197,338
1.7
Yeleswaram Krishnaswamy Chief Development Officer Officer
Transaction date
Sale
Price
30.05
Quantity 2,840 -0.9%
Value US$85,342
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
31.04
Quantity 515 -1.6%
Value US$15,985
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.04
Quantity 2,421 -7.2%
Value US$72,722
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.84
Quantity 2,147 -6.0%
Value US$61,925
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
31.04
Quantity 600 -0.1%
Value US$18,622
Ceesay Abraham Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.04
Quantity 2,792 -0.5%
Value US$83,862
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
49,859 +37.7%
304.97
US$750,394 		49,859 +37.7% 304.97 US$750,394
2026-09-09 2026-09-08 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
76,958 -21.1%
123.15
US$2,974,856 		76,958 -21.1% 123.15 US$2,974,856
2026-08-26 2026-08-25 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
25,887 -45.5%
455.03
US$3,114,219 		25,887 -45.5% 455.03 US$3,114,219
2026-08-26 2026-08-25 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
20,799 -8.9%
50.31
US$1,046,421 		20,799 -8.9% 50.31 US$1,046,421
2026-08-26 2026-08-25 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
18,921 -3.9%
49.57
US$937,957 		18,921 -3.9% 49.57 US$937,957
2026-08-25 2026-08-25 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
37,000
49.33
US$1,825,210 		37,000 49.33 US$1,825,210
2026-08-26 2026-08-24 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
13,160 -5.3%
50.00
US$657,978 		13,160 -5.3% 50.00 US$657,978
2026-08-24 2026-08-24 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
11,472
48.24
US$553,409 		11,472 48.24 US$553,409
2026-08-20 2026-08-19 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
404 -0.2%
49.90
US$20,160 		404 -0.2% 49.90 US$20,160
2026-08-19 2026-08-19 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
2,092
49.01
US$102,529 		2,092 49.01 US$102,529
2026-08-12 2026-08-11 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,794 -1.2%
48.62
US$281,721 		5,794 -1.2% 48.62 US$281,721
2026-08-12 2026-08-11 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
19,500 -3.8%
48.04
US$936,846 		19,500 -3.8% 48.04 US$936,846
2026-08-12 2026-08-11 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,664 -0.7%
46.90
US$171,837 		3,664 -0.7% 46.90 US$171,837
2026-08-12 2026-08-10 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
8,370 -1.6%
46.75
US$391,280 		8,370 -1.6% 46.75 US$391,280
2026-08-12 2026-08-10 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
14,171 -2.6%
45.97
US$651,492 		14,171 -2.6% 45.97 US$651,492
2026-07-29 2026-07-27 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
7 -0.0%
42.74
US$299 		7 -0.0% 42.74 US$299
2026-07-29 2026-07-27 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,203 -0.4%
42.11
US$92,762 		2,203 -0.4% 42.11 US$92,762
2026-07-15 2026-07-14 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,729 -0.5%
40.57
US$110,722 		2,729 -0.5% 40.57 US$110,722
2026-07-15 2026-07-14 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,481 -1.0%
39.72
US$217,715 		5,481 -1.0% 39.72 US$217,715
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
1,000 -0.7%
43.15
US$43,155 		1,000 -0.7% 43.15 US$43,155
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
3,308 -2.1%
42.17
US$139,506 		3,308 -2.1% 42.17 US$139,506
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
3,792 -2.4%
41.39
US$156,964 		3,792 -2.4% 41.39 US$156,964
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
1,900 -1.2%
40.09
US$76,174 		1,900 -1.2% 40.09 US$76,174
2026-06-30 2026-06-30 PrS Proposed sale
0.6
CHERYL GAULT

Officer

Officer
10,000
40.39
US$403,900 		10,000 40.39 US$403,900
2026-07-01 2026-06-29 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
876 -0.2%
40.34
US$35,336 		876 -0.2% 40.34 US$35,336
2026-07-01 2026-06-29 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
7,344 -1.3%
39.77
US$292,062 		7,344 -1.3% 39.77 US$292,062
2026-06-29 2026-06-29 PrS Proposed sale
Abraham N. Ceesay

Officer

Officer
99,480
40.39
US$4,017,997 		99,480 40.39 US$4,017,997
2026-05-28 2026-05-26 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
18,572 -0.3%
40.05
US$743,753 		18,572 -0.3% 40.05 US$743,753
2026-05-27 2026-05-26 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
18,572
40.00
US$742,880 		18,572 40.00 US$742,880
2026-05-13 2026-05-11 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
133,618 -2.1%
40.24
US$5,377,323 		133,618 -2.1% 40.24 US$5,377,323
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
133,618
40.25
US$5,378,124 		133,618 40.25 US$5,378,124
2026-05-11 2026-05-08 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
5,018 -0.1%
40.31
US$202,256 		5,018 -0.1% 40.31 US$202,256
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-11 2026-05-07 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
271,495 -4.0%
40.12
US$10,892,651 		271,495 -4.0% 40.12 US$10,892,651
2026-05-07 2026-05-07 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
271,495
40.12
US$10,892,705 		271,495 40.12 US$10,892,705
2026-04-21 2026-04-17 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
426,005 -6.0%
40.32
US$17,175,244 		426,005 -6.0% 40.32 US$17,175,244
2026-04-21 2026-04-17 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
20,225 -7.6%
39.99
US$808,844 		20,225 -7.6% 39.99 US$808,844
2026-04-17 2026-04-17 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
20,225
39.54
US$799,696 		20,225 39.54 US$799,696
2026-04-17 2026-04-17 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
426,005
40.32
US$17,175,116 		426,005 40.32 US$17,175,116
2026-04-14 2026-04-14 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,200 -3.7%
35.08
US$357,797 		10,200 -3.7% 35.08 US$357,797
2026-04-14 2026-04-13 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
9,165 -3.2%
34.97
US$320,537 		9,165 -3.2% 34.97 US$320,537
2026-04-13 2026-04-13 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
19,365
34.17
US$661,702 		19,365 34.17 US$661,702
2026-04-14 2026-04-10 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
500 -0.2%
34.98
US$17,490 		500 -0.2% 34.98 US$17,490
2026-04-10 2026-04-10 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
500
34.22
US$17,110 		500 34.22 US$17,110
2026-04-09 2026-04-08 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
360 -0.1%
34.90
US$12,564 		360 -0.1% 34.90 US$12,564
2026-04-08 2026-04-08 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
360
33.49
US$12,056 		360 33.49 US$12,056
2026-03-31 2026-03-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
2,839 -1.7%
28.55
US$81,062 		2,839 -1.7% 28.55 US$81,062
2026-03-31 2026-03-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
7,161 -4.2%
28.04
US$200,795 		7,161 -4.2% 28.04 US$200,795
2026-03-30 2026-03-30 PrS Proposed sale
0.6
CHERYL GAULT

Officer

Officer
10,000
27.84
US$278,400 		10,000 27.84 US$278,400
2026-03-26 2026-03-25 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,115 -3.4%
29.99
US$303,355 		10,115 -3.4% 29.99 US$303,355
2026-03-25 2026-03-25 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
10,115
28.25
US$285,749 		10,115 28.25 US$285,749
2026-03-09 2026-03-05 S Sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
2,014 -1.2%
28.93
US$58,265 		2,014 -1.2% 28.93 US$58,265
2026-03-05 2026-03-05 PrS Proposed sale
0.6
Gault Cheryl

Officer

Officer
2,014
28.92
US$58,236 		2,014 28.92 US$58,236
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,100 -9.2%
29.80
US$62,573 		2,100 -9.2% 29.80 US$62,573
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,983 -11.6%
29.04
US$86,639 		2,983 -11.6% 29.04 US$86,639
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,281 -0.4%
29.80
US$67,970 		2,281 -0.4% 29.80 US$67,970
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,552 -0.6%
29.05
US$103,191 		3,552 -0.6% 29.05 US$103,191
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
2,200 -0.6%
29.59
US$65,108 		2,200 -0.6% 29.59 US$65,108
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,400 -1.4%
28.95
US$156,328 		5,400 -1.4% 28.95 US$156,328
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
900 -0.2%
28.02
US$25,219 		900 -0.2% 28.02 US$25,219
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,083 -16.5%
26.11
US$132,737 		5,083 -16.5% 26.11 US$132,737
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,833 -1.0%
26.12
US$152,333 		5,833 -1.0% 26.12 US$152,333
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
200 -0.1%
27.40
US$5,480 		200 -0.1% 27.40 US$5,480
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
8,300 -2.1%
26.83
US$222,652 		8,300 -2.1% 26.83 US$222,652
2026-01-15 2026-01-15 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
17,000
27.42
US$466,140 		17,000 27.42 US$466,140
2026-01-02 2026-01-02 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
6,567
30.05
US$197,338 		6,567 30.05 US$197,338
2026-01-02 2026-01-02 PrS Proposed sale
1.7
Krishnaswamy Yeleswaram

Officer

Officer
2,840
30.05
US$85,343 		2,840 30.05 US$85,343
2026-01-05 2025-12-31 S Sale
1.7
Bredt David

Chief Scientific Officer

Officer
6,567 -1.6%
30.05
US$197,338 		6,567 -1.6% 30.05 US$197,338
2026-01-05 2025-12-31 S Sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
2,840 -0.9%
30.05
US$85,342 		2,840 -0.9% 30.05 US$85,342
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
515 -1.6%
31.04
US$15,985 		515 -1.6% 31.04 US$15,985
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,421 -7.2%
30.04
US$72,722 		2,421 -7.2% 30.04 US$72,722
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,147 -6.0%
28.84
US$61,925 		2,147 -6.0% 28.84 US$61,925
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
600 -0.1%
31.04
US$18,622 		600 -0.1% 31.04 US$18,622
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,792 -0.5%
30.04
US$83,862 		2,792 -0.5% 30.04 US$83,862
Explore more

More insider trading research around Rapport Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America